HeartSciences Profit Margin 2022-2024 | HSCS

Current and historical gross margin, operating margin and net profit margin for HeartSciences (HSCS) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. HeartSciences net profit margin as of January 31, 2024 is 0%.
HeartSciences Annual Profit Margins
HeartSciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.006B $0.000B
HeartSciences is an artificial intelligence powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The company's product candidate includes the MyoVista(R) wavECG(TM) or the MyoVista(R). HeartSciences , formerly known as Heart Test Laboratories Inc., is based in Southlake, TX.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.194B 0.00
IRhythm Technologies (IRTC) United States $3.483B 0.00
Axonics (AXNX) United States $3.401B 0.00
10x Genomics (TXG) United States $3.288B 0.00
Enovis (ENOV) United States $3.030B 23.02
Azenta (AZTA) United States $2.910B 237.18
Olink Holding AB (publ) (OLK) Sweden $2.840B 0.00
Hims & Hers Health (HIMS) United States $2.678B 0.00
Privia Health (PRVA) United States $2.167B 96.11
Schrodinger (SDGR) United States $1.733B 0.00
Omnicell (OMCL) United States $1.279B 31.30
Phreesia (PHR) United States $1.162B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.762B 0.00
Standard BioTools (LAB) United States $0.708B 0.00
Fulgent Genetics (FLGT) United States $0.601B 0.00
Talkspace (TALK) United States $0.527B 0.00
Health Catalyst (HCAT) United States $0.353B 0.00
Clover Health Investments (CLOV) United States $0.337B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.328B 0.00
Pulmonx (LUNG) United States $0.281B 0.00
Butterfly Network (BFLY) United States $0.162B 0.00
American Well (AMWL) United States $0.153B 0.00
MSP Recovery (LIFW) United States $0.141B 0.00
P3 Health Partners (PIII) United States $0.141B 0.00
Augmedix (AUGX) United States $0.139B 0.00
Outset Medical (OM) United States $0.124B 0.00
TruBridge (TBRG) United States $0.118B 5.03
111 (YI) China $0.086B 0.00
SHL Telemedicine (SHLT) Israel $0.082B 0.00
Future Health ESG (FHLT) United States $0.073B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.048B 0.00
Movano (MOVE) United States $0.047B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Akili (AKLI) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.018B 0.00
CareCloud (CCLD) United States $0.017B 0.00
ETAO (ETAO) United States $0.015B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00